Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan
Clinical trial NCT02648217 · COMPLETED
Trial details
- NCT number
- NCT02648217
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-04
- Primary completion
- 2016-09-04
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.